Generic Placeholder Website Image

Activity content starts in:

Industry Webcast

Treating Excessive Daytime Sleepiness due to OSA: Translating Clinical Trial Endpoints Into PracticeIndustry Webcast Sponsored by Axsome Therapeutics, Inc.; Not for CME/CE Credit

This presentation explores an overview of the impact of Excessive Daytime Sleepiness due to Obstructive Sleep Apnea. It reviews clinical data on a therapy for Excessive Daytime Sleepiness including patient reported outcomes, functional outcomes, and important safety information

Watch

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 10/14/2026

Expiration Date: 10/14/2026

Faculty

Faculty

Supporters and Partners

Industry Sponsor

Axsome Therapeutics, Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Treating Excessive Daytime Sleepiness due to OSA: Translating Clinical Trial Endpoints Into Practice

Watch